Tigecycline Penetration into Skin and Soft Tissue

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Surgical Infections

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/sur.2011.022PMID 22136488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of tigecycline in human skin using a novel validated LC-MS/MS method.

  2010cited by this paper
• Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using In Vivo Microdialysis

  2010cited by this paper
• Complicated skin and soft tissue infection.

  2010cited by this paper
• Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Pharmacodynamic Evaluation and Comparison with Isogenic Normal-Phenotype and Revertant Strains

  2009cited by this paper
• Guidance for Antibiotic Selection: Tissue Distribution and Target Site Concentration

  2009cited by this paper
• Single-Agent Therapy With Tigecycline in the Treatment of Complicated Skin and Skin Structure and Complicated Intraabdominal Infections

  2009cited by this paper
• Treatment of Complicated Skin and Soft Tissue Infections

  2009cited by this paper
• Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.

  2008cited by this paper
• Clinical Microdialysis in Skin and Soft Tissues: An Update

  2008cited by this paper
• Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure Infections

  2007cited by this paper
• Tissue concentrations: do we ever learn?

  2007cited by this paper
• Population Pharmacokinetics of Tigecycline in Patients with Complicated Intra-Abdominal or Skin and Skin Structure Infections

  2006cited by this paper
• Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.

  2006cited by this paper
• Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.

  2006cited by this paper
• Pharmacokinetic Profile of Tigecycline in Serum and Skin Blister Fluid of Healthy Subjects after Multiple Intravenous Administrations

  2005cited by this paper
• Quantitation of tigecycline, a novel glycylcycline [corrected] by liquid chromatography.

  2004cited by this paper
• Quantitation of tigecycline, a novel glycyclcycline, by liquid chromatography

  2004cited by this paper

• T cell toxicity induced by tigecycline binding to the mitochondrial ribosome

  2025cites this paper
• Pharmacokinetic/pharmacodynamic evaluation of tigecycline dosing in a hollow fiber infection model against clinical bla-KPC producing Klebsiella Pneumoniae isolates.

  2023cites this paper
• Antibiotics in Necrotizing Soft Tissue Infections

  2021cites this paper
• Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review

  2021cites this paper
• Cutaneous Hyperpigmentation Secondary to High-Dose Tigecycline: A Case Report

  2020cites this paper
• Impact of tigecycline versus imipenem–cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study

  2018cites this paper
• Clinical features and treatment of patients with Vibrio vulnificus infection.

  2017cites this paper
• Prescription Patterns for Tigecycline in Severely Ill Patients for Non-FDA Approved Indications in a Developing Country: A Compromised Outcome

  2017cites this paper
• Impact of bacterial load on pharmacodynamics and susceptibility breakpoints for tigecycline and Klebsiella pneumoniae

  2017cites this paper
• New therapeutic options for skin and soft tissue infections

  2016cites this paper
• Impact of evolving epidemiology on treatments for complicated skin and skin structure infections: the surgical perspective.

  2015cites this paper
• Re-defining tigecycline therapy.

  2015influential citation
• Novel antibiotic treatment for skin and soft tissue infection

  2014cites this paper
• Current concept of abdominal sepsis: WSES position paper

  2014cites this paper
• World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections

  2014cites this paper
• Odontogenic Descending Necrotizing Mediastinitis in a Patient with Severe Allergy to Beta-Lactam Antibiotics: A Case Report and Literature Review

  2013cites this paper
• Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.

  2013cites this paper
• Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies.

  2013cites this paper
• New Therapeutic Weapon in the Treatment of Refractory Acute Diverticulitis

  2012cites this paper
• The effect of ethanol on cholesterol crystals during tissue preparation for scanning electron microscopy.

  2012cites this paper
• Structural Basis of T Cell Toxicity Induced by Tigecycline Binding to the Mitochondrial Ribosome

  year unknowncites this paper